Latest Morning Briefing Stories
杨贵妃传媒視頻 Health News' 'What the Health?': American Health Gets a Pink Slip
The Department of Health and Human Services underwent an unprecedented purge this week, as thousands of employees from the National Institutes of Health, the FDA, the Centers for Disease Control and Prevention, and other agencies were fired, placed on administrative leave, or offered transfers to far-flung Indian Health Service facilities. Altogether, the layoffs mean the federal government, in a single day, shed hundreds if not thousands of combined years of health and science expertise. Lauren Weber of The Washington Post, Rachel Cohrs Zhang of Bloomberg News, and Sarah Karlin-Smith of the Pink Sheet join 杨贵妃传媒視頻 Health News鈥 Julie Rovner to discuss this enormous breaking story and more. Also this week, Rovner interviews 杨贵妃传媒視頻 Health News鈥 Julie Appleby, who reported and wrote the latest 鈥淏ill of the Month鈥 feature about a short-term health plan and a very expensive colonoscopy.
Hit Hard by Opioid Crisis, Black Patients Further Hurt by Barriers to Care
The rate of overdose deaths from opioids has grown significantly among Black people. Yet, even after a nonfatal overdose, this group is half as likely to be referred to or get treatment compared with white people. Advocates and researchers cite implicit bias, insurance denials, and other systemic issues.
Montana鈥檚 Small Pharmacies Behind Bill To Corral Pharmacy Benefit Managers
A bill designed to force PBMs to pay higher fees to independent drugstores sailed through the state House, but lobbyists are marshaling their forces to kill the measure in the Senate.
杨贵妃传媒視頻 Health News' 'What the Health?': Federal Health Work in Flux
It鈥檚 the Trump administration vs. the federal courts, as the Department of Government Efficiency continues to try to cancel federal contracts and programs and fire workers. But in the haste to cut things, jobs and programs are being eliminated even if they align with the new administration鈥檚 goal to 鈥淢ake America Healthy Again.鈥 Jessie Hellmann of CQ Roll Call, Sarah Karlin-Smith of the Pink Sheet, and Rachel Roubein of The Washington Post join 杨贵妃传媒視頻 Health News鈥 Julie Rovner to discuss these stories and more.
Scientists Say NIH Officials Told Them To Scrub mRNA References on Grants
Two senior scientists say National Institutes of Health officials advised them to remove references to mRNA vaccines in grant applications, and they fear the Trump administration will abandon a promising field of medical research.
With RFK Jr. in Charge, Supplement Makers See Chance To Cash In
The FDA is already limited in policing claims of health benefits by makers of supplements and herbal remedies 鈥 a $70 billion industry. Get ready for even less regulation.
Journalists Discuss Health Care for Incarcerated Children and the Possibility of a Bird Flu Pandemic
杨贵妃传媒視頻 Health News journalists made the rounds on national and local media recently to discuss topical stories. Here鈥檚 a collection of their appearances.
Pain Clinics Made Millions From 鈥楿nnecessary鈥 Injections Into 鈥楬uman Pin Cushions鈥
Pain MD, which once ran as many as 20 clinics across three states, gave chronic-pain patients about 700,000 total injections near their spines, according to court documents. Last year, federal prosecutors proved at trial that the shots were medically unnecessary and part of an extensive fraud scheme.
Top California Democrats Clash Over How To Rein In Drug Industry Middlemen
Frustrated by spiraling drug costs, California lawmakers want to increase oversight of pharmaceutical industry intermediaries known as pharmacy benefit managers. It鈥檚 unclear whether they can persuade Gov. Gavin Newsom to get on board.
Long-Covid Patients Are Frustrated That Federal Research Hasn’t Found New Treatments
The federal government has allocated $1.15 billion to long-covid research without any new treatments yet brought to market. Patients and scientists say it鈥檚 time to push harder for breakthroughs.
Health Care Is Newsom鈥檚 Biggest Unfinished Project. Trump Complicates That Task.
As Gov. Gavin Newsom enters the second half of his final term, health care stands out as his most ambitious but glaringly incomplete initiative for California residents. The issue will likely shape his national profile for better or worse. And now, Donald Trump brings a new wrinkle.
La salud, un proyecto inconcluso del gobernador de California
Algunas de las iniciativas emblem谩ticas de Newsom en materia de salud, que podr铆an definir su perfil en el escenario nacional, est谩n en peligro con el regreso de Donald Trump a la Casa Blanca.
鈥楤ill of the Month鈥: The Series That Dissects and Slashes Medical Bills
Since 2018, readers and listeners sent 杨贵妃传媒視頻 Health News-NPR鈥檚 鈥淏ill of the Month鈥 thousands of questionable bills. Our crowdsourced investigation paved the way for landmark legislation and highlighted cost-saving strategies for all patients.
Employers Press Congress To Cement Health Price Transparency Before Trump鈥檚 Return
Donald Trump鈥檚 first administration advanced rules forcing hospitals and insurers to reveal prices for medical services. Employers don鈥檛 want to risk backtracking during Trump鈥檚 second administration.
Readers Offer ‘Solo Agers’ Support and Reflect on Ancestors
杨贵妃传媒視頻 Health News gives readers a chance to comment on a recent batch of stories.
How a Duty To Spend Wisely on Worker Benefits Could Loosen PBMs鈥 Grip on Drug Prices
As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the 鈥淏ig Three鈥 PBMs 鈥 or force them to change.
Rage Has Long Shadowed American Health Care. It鈥檚 Rarely Produced Big Change.
The outpouring of anger at health insurers following the killing of UnitedHealthcare CEO Brian Thompson continues a cycle of rage that dates back decades.
Florida鈥檚 Canada Drug Importation Plan Has Yet to Launch
Florida Gov. Ron DeSantis (R) spent years complaining that the Biden administration was slow-walking federal approval of his plan to import lower-cost prescription drugs from Canada 鈥 a concept endorsed by Donald Trump in 2020 just before his first presidential term ended. But nearly a year since the Food and Drug Administration green-lit the state鈥檚 […]
Who Gets Obesity Drugs Covered by Insurance? In North Carolina, It Helps If You鈥檙e on Medicaid
GLP-1 agonist medications such as Ozempic accounted for 10% of the North Carolina state employee health plan鈥檚 prescription drug spending, so the state is no longer covering them for weight loss alone. Still, it did decide to cover them for Medicaid patients鈥 weight loss. A look inside the state鈥檚 coverage calculus.
驴Podr铆an los nuevos medicamentos para bajar de peso estar disponibles para todos?
Los medicamentos agonistas GLP-1, conocidos por los nombres comerciales Ozempic, Trulicity y Wegovy, han demostrado ser efectivos para la p茅rdida de peso y para el manejo de la diabetes tipo 2.
